Lappas M et al. |
Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. |
2004 Sep-Oct |
Placenta |
pmid:15450387
|
Yuan J et al. |
Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. |
2005 |
Urology |
pmid:15780399
|
Marshall JC |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? |
2005 |
Intensive Care Med |
pmid:15782317
|
Liu J et al. |
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15838654
|
Ji JD et al. |
Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. |
2005 |
Rheumatology (Oxford) |
pmid:15840591
|
Usui S et al. |
Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15745794
|
Storer PD et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neuroimmunol. |
pmid:15748950
|
Mochizuki M et al. |
Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:15750045
|
Viñals M et al. |
Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. |
2005 |
Cardiovasc. Res. |
pmid:15769457
|
Yuan Z et al. |
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. |
2005 |
Heart |
pmid:15774612
|
Inoue K et al. |
Effects of 15-deoxy-delta(12,14)-prostaglandin J2 on nuclear localization of GATA-3 in the murine lung in the presence of lipopolysaccharide. |
2005 |
Arzneimittelforschung |
pmid:15819389
|
Sanchez-Rodriguez J et al. |
The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells. |
2005 |
Biochem. J. |
pmid:15819613
|
Hwang J et al. |
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. |
2005 |
Am. J. Physiol., Cell Physiol. |
pmid:15590897
|
Chou YH et al. |
The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. |
2005 |
Int. J. Biochem. Cell Biol. |
pmid:15618017
|
Coyle AT et al. |
15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. |
2005 |
FEBS J. |
pmid:16156795
|
O'Flaherty JT et al. |
5-Oxo-ETE analogs and the proliferation of cancer cells. |
2005 |
Biochim. Biophys. Acta |
pmid:16154383
|
Koh SH et al. |
15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant? |
2005 |
Toxicology |
pmid:16191461
|
Gayarre J et al. |
Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. |
2005 |
FEBS Lett. |
pmid:16223487
|
Kobayashi Y et al. |
Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. |
2005 |
J. Immunol. |
pmid:16237065
|
Iwata C et al. |
Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. |
2005 |
J. Invest. Dermatol. |
pmid:16297182
|
Bianchi A et al. |
Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. |
2005 |
Arthritis Res. Ther. |
pmid:16277686
|
Muñoz U et al. |
The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients. |
2005 |
Exp. Neurol. |
pmid:16061222
|
Polikandriotis JA et al. |
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16020752
|
Kim KA et al. |
15d-Deoxy-Delta12,14-prostaglandin J2 modulates collagen type I synthesis in human hepatic stellate cells by inducing oxidative stress. |
2005 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:16098720
|
MartÃnez B et al. |
The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action. |
2005 |
J. Lipid Res. |
pmid:15654126
|
Liang X et al. |
Prostaglandin D2 mediates neuronal protection via the DP1 receptor. |
2005 |
J. Neurochem. |
pmid:15659218
|
Shen ZN et al. |
Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15694358
|
Shiraki T et al. |
Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. |
2005 |
J. Biol. Chem. |
pmid:15695504
|
GarcÃa-Bueno B et al. |
The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. |
2005 |
Psychopharmacology (Berl.) |
pmid:15719215
|
Storer PD et al. |
Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neurosci. Res. |
pmid:15723383
|
Migita H and Morser J |
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15662020
|
Tanaka T et al. |
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. |
2005 |
Eur. J. Pharmacol. |
pmid:15680279
|
Hosoya T et al. |
Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. |
2005 |
J. Biol. Chem. |
pmid:15917255
|
Andrews WJ et al. |
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. |
2005 |
J. Steroid Biochem. Mol. Biol. |
pmid:15862961
|
Allred CD and Kilgore MW |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. |
2005 |
Mol. Cell. Endocrinol. |
pmid:15866424
|
Marzocco S et al. |
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. |
2005 |
Intensive Care Med |
pmid:15868139
|
Blanco M et al. |
Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. |
2005 |
Stroke |
pmid:15879329
|
Ackerman WE et al. |
Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. |
2005 |
Biol. Reprod. |
pmid:15843495
|
Drew PD et al. |
Hormone regulation of microglial cell activation: relevance to multiple sclerosis. |
2005 |
Brain Res. Brain Res. Rev. |
pmid:15850670
|
Patel KM et al. |
Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). |
2005 |
Cell. Signal. |
pmid:15993751
|
Kim HJ et al. |
15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. |
2005 |
Exp. Mol. Med. |
pmid:16000871
|
Pande V and Ramos MJ |
Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:16006125
|
Eggler AL et al. |
Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16006525
|
Matsuzaki Y et al. |
15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. |
2005 |
Int. J. Oncol. |
pmid:16010433
|
Kaplan JM et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. |
2005 |
Shock |
pmid:15988322
|
Burgess HA et al. |
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:15734787
|
Inoue K et al. |
Effects of 15-deoxy-Delta12,14-prostaglandin J2 on the expression of Toll-like receptor 4 and 2 in the murine lung in the presence of lipopolysaccharide. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:15743408
|
Berry EB et al. |
Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. |
2005 |
Mol. Pharmacol. |
pmid:15821150
|
Lindström TM and Bennett PR |
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15755849
|
Takashima T et al. |
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. |
2005 |
Oncol. Rep. |
pmid:15756430
|